Pfizer's COVID-19 antiviral Paxlovid cut the prevalence of hospitalizations and deaths in half when it was used within the first day of diagnosis, according to a study published Dec. 16 in Nature.
A popular class of drugs for weight loss and Type 2 diabetes might help lower the prevalence of heart disease, according to a study published Dec. 18 in Cell Metabolism.
The Novo Nordisk Foundation, the philanthropic arm of the Danish pharmaceutical giant, announced Dec. 18 that it has committed $260 million toward the development and improvement of respiratory virus vaccines.
Georgia had been ramping up to become the first state to allow pharmacies to dispense medical cannabis. Now the Drug Enforcement Administration is warning pharmacies in the state that doing so would violate federal law.
Some patients taking Ozempic (semaglutide) are considering skipping doses to indulge during the winter holidays, but a short break in the regimen can spur health issues, according to a UCLA physician.
Bristol Myers Squibb is ending a phase 3 clinical trial of a combination treatment for metastatic colorectal cancer after an independent committee determined it was unlikely to produce meaningful results, the drugmaker said Dec. 15.
Mark Cuban Cost Plus Drug Co. has announced a partnership with pharmacy benefit management company PCA Rx to bring members even more clarity about drug pricing, according to a Dec. 18 news release. The company is now the fourth PBM…
The FDA placed a clinical hold on three trials for CAR-T medications made by China-based CARsgen Therapeutics after inspecting a manufacturing site in Durham, N.C.
